Via rawpixel.com In a groundbreaking advance against the escalating crisis of antibiotic resistance, researchers at MIT have harnessed artificial intelligence to design entirely new antibiotics capable of tackling two notorious drug-resistant bacteria. The antibiotics can be used to treat Neisseria gonorrhoeae, the culprit behind gonorrhea, and methicillin-resistant Staphylococcus aureus (MRSA), a common cause of severe skin and bloodstream infections. The study, published today in the journal Cell, comes at a critical time. Over the past 45 years, the FDA has approved only a handful of new antibiotics, most of which are mere tweaks on existing drugs. Meanwhile, bacterial resistance has surged, contributing to nearly 5 million deaths annually worldwide from drug-resistant infections. Traditional drug discovery methods, reliant on screening known chemical libraries, have struggled to…
Click here to read the full article at The Gateway Pundit.
